InspireMD (STU:II2) Cyclically Adjusted Book per Share: €0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:II2 InspireMD Inc STU:II2
51 GF Score
Price €0.84
GF Value €1.47
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Cyclically Adjusted Book per Share?

InspireMD STU:II2 +16.78% 51 Cyclically Adjusted Book per Share is €0.00 as of Jun. 2026. GuruFocus rates STU:II2 with a GF Score™ of 51/100 and a GF Value™ of €1.47 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

InspireMD's adjusted book value per share for the three months ended in Jun. 2026 was €0.323. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, InspireMD's average Cyclically Adjusted Book Growth Rate was -8.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -11.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of InspireMD was -11.30% per year. The lowest was -26.90% per year. And the median was -14.80% per year.

As of today (2026-08-17), InspireMD's current stock price is €0.835. InspireMD's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €0.00. InspireMD's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of InspireMD was 0.31. The lowest was 0.01. And the median was 0.02.


InspireMD  (STU:II2) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of InspireMD was 0.31. The lowest was 0.01. And the median was 0.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


InspireMD Cyclically Adjusted Book per Share Related Terms


InspireMD Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for InspireMD's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD Cyclically Adjusted Book per Share Chart

InspireMD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 380.74 156.42 120.92 122.57 101.93

InspireMD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.57 101.08 101.93 96.79 0.00

STU:II2 vs TELA, BDMD, PAVM: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, InspireMD's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where InspireMD's Cyclically Adjusted PB Ratio falls into.


STU:II2
51GF Score
InspireMD Inc STU:II2
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InspireMD Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InspireMD's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.323/333.9520*333.9520
=0.323

Current CPI (Jun. 2026) = 333.9520.

InspireMD Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 1,152.000 246.524 1,560.549
201803 169.400 249.554 226.690
201806 389.778 251.989 516.559
201809 191.551 252.439 253.403
201812 151.039 251.233 200.769
201903 293.588 254.202 385.694
201906 53.043 256.143 69.156
201909 31.174 256.759 40.546
201912 18.563 256.974 24.124
202003 10.889 258.115 14.088
202006 5.276 257.797 6.835
202009 3.984 260.280 5.112
202012 3.044 260.474 3.903
202103 4.702 264.877 5.928
202106 4.282 271.696 5.263
202109 3.988 274.310 4.855
202112 3.577 278.802 4.285
202203 3.242 287.504 3.766
202206 2.926 296.311 3.298
202209 2.650 296.808 2.982
202212 1.971 296.797 2.218
202303 1.506 301.836 1.666
202306 2.039 305.109 2.232
202309 1.894 307.789 2.055
202312 1.658 306.746 1.805
202403 1.379 312.332 1.474
202406 1.724 314.175 1.833
202409 1.449 315.301 1.535
202412 1.295 315.605 1.370
202503 0.881 319.799 0.920
202506 0.539 322.561 0.558
202509 1.303 324.800 1.340
202512 1.083 324.054 1.116
202603 0.806 330.213 0.815
202606 0.323 333.952 0.323

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.00 mean?
InspireMD (STU:II2) has a Cyclically Adjusted Book per Share of €0.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on InspireMD and its competitors.
Is InspireMD's Cyclically Adjusted Book per Share too high?
InspireMD's current Cyclically Adjusted Book per Share is €0.00. Overall, InspireMD has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InspireMD's Cyclically Adjusted Book per Share compare to TELA and BDMD?
InspireMD's Cyclically Adjusted Book per Share of €0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on InspireMD and its competitors. InspireMD's current Cyclically Adjusted Book per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InspireMD stock overvalued right now?
Based on GuruFocus' analysis, InspireMD (STU:II2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.47, compared to a current price of €0.84 — trading 43.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is €0.00. InspireMD's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For InspireMD (STU:II2), the current Cyclically Adjusted Book per Share is €0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.84 is trading 43.2% below its estimated GF Value™ of €1.47. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

  • Cyclically Adjusted Book per Share: €0.00
  • GF Value™: €1.47 vs. price of €0.84 (43.2% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InspireMD Business Description

Other Exchanges NSPR:USA
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
51GF Score

Get the complete analysis for STU:II2

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€1.47
GF Value